Basic Calan Information

• INN (International Nonproprietary Name): Verapamil
• Brand Names Available In Canada (English): Calan (US discontinued), Calan SR (US), Isoptin SR (Europe, Canada), Covera-HS (US), Verelan (US), Verelan PM (US), and generic “Verapamil” products worldwide; packaging and brand presence vary by region.
• ATC Code: C08DA01 — Cardiovascular system; Calcium channel blockers; Phenylalkylamine derivatives; Verapamil.
• Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended-release tablets 120 mg, 180 mg, 240 mg; Extended-release capsules 100 mg, 120 mg, 180 mg, 240 mg; Intravenous solution (US) 2.5 mg/mL (5 mg/2 mL ampoules).
• Manufacturers In Canada (English): Global manufacturers noted in registries include Abbott, Pfizer, Mylan, Teva, Sandoz and other generic manufacturers; local suppliers and packagers vary and are not specified for every provincial market.
• Registration Status In Canada (English): Prescription-only (Rx-only) in most regions according to available registration summaries.
• OTC / Rx Classification: Rx-only (prescription required).

Availability & Price Landscape

Where can I find calan or verapamil in Canada, and what will it cost me?

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Shoppers Drug Mart, Rexall and London Drugs commonly stock verapamil as generics and selected sustained‑release brands such as Isoptin SR where available.

Availability of specific strengths — for example 120 mg extended‑release — varies by store and by province, so a quick phone check or online stock lookup is often needed.

Generic verapamil is generally easier to source in community retail chains than former US‑branded Calan, which is discontinued in the US.

Branded SR products such as Isoptin SR are available in some stores but tend to be stocked less widely and may require special order.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Canadian online pharmacies increasingly accept uploaded prescriptions and deliver verapamil across provinces using secure workflows.

Provincial regulation and pharmacists’ scope of practice mean dispensing workflows differ between Ontario, British Columbia and Quebec; for example, pharmacist renewals or adaptations may be allowed in some provinces but not others.

When ordering online, choose pharmacies that display business licences and DINs for each pack, and that require a valid prescription before shipping.

In our online pharmacy, calan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Price Ranges By Package Size (With Provincial Differences)

Expect generic verapamil tablet or ER 30–90 day packs to range roughly between CAD 8 and CAD 45 depending on manufacturer, strength and retailer.

Pack price differences reflect strength (higher‑strength ER packs cost more), pack size, and whether the product is a brand (Isoptin SR) or generic.

Provincial drug plans — such as Ontario Drug Benefit, BC PharmaCare and RAMQ — may cover verapamil for eligible groups, but eligibility rules and copays differ between provinces and patient categories.

Recommended purchasing steps:

• Check the required strength and ER vs IR formulation on your prescription.
• Confirm the pack DIN on the product page or ask the pharmacist for the DIN.
• Compare prices at local chains and licensed online pharmacies and check provincial formulary coverage if eligible.
• When importing, verify customs rules and note products without a Canadian DIN may not be reimbursable.

Canadian Patient Insights & Satisfaction Levels

What do Canadians say about verapamil on forums and review sites?

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Conversations about verapamil and Isoptin SR appear across Reddit Canada, HealthBoards and provincial patient forums.

Many posts describe starting or titrating verapamil for atrial fibrillation rate control or angina symptom relief and then following up with a pharmacist or cardiologist.

Forum reports often note differences in tolerability when switching generic manufacturers, and requests for practical advice about constipation and interactions are common.

Reported Benefits And Challenges From Canadian Patients

Patients commonly report good rate control for atrial fibrillation and improvement in angina symptoms.

Frequent challenges include constipation, fatigue, ankle swelling and sometimes lightheadedness, which align with Health Canada safety profiles and known side effects.

Some patients mention paying CAD 10–40 for generics when not covered by a provincial plan.

Patient pros and cons — quick summary:

• Pros: Effective AV nodal suppression, useful for atrial fibrillation and angina; ER forms allow simpler dosing.
• Cons: Constipation, bradycardia risks, drug interactions (notably with beta‑blockers and digoxin) and variability when switching generics.

Pull‑quote examples seen on forums:

• “Switched to verapamil ER and my heart rate at rest dropped into target range.”
• “Constipation got better after adding fibre and talking with my pharmacist at Shoppers.”

Product Overview & Brand Variants

What exactly is in the bottle and how is it labelled in Canada?

INN And Brand Names Used In Canada

The INN for the product is verapamil.

In Canada the market features generic verapamil and branded sustained‑release formulations such as Isoptin SR.

Calan as a US retail brand is discontinued in the US, though Calan SR and other brand names exist internationally.

Legal Classification Under Health Canada

Verapamil-containing products are prescription-only (Rx) under typical regulatory listings.

When a specific manufacturer pack is selected on a product page, display the DIN prominently to link the product to Health Canada’s database and formulary decisions.

INN

International Nonproprietary Name — the generic drug name (Verapamil).

DIN

Drug Identification Number — links a specific product pack to Health Canada records.

ER/SR

Extended Release / Sustained Release — formulations that release the drug more slowly to allow once or twice daily dosing.

Indications In Local Canadian Medical Practice

When will a prescriber in Canada choose verapamil, and what about off‑label uses?

Approved Uses (Health Canada DIN Context)

Verapamil is indicated for hypertension, angina pectoris and certain supraventricular arrhythmias including atrial fibrillation/flutter and PSVT.

On product pages, list approved indications per the manufacturer monograph and cross‑reference the DIN-linked Health Canada entry.

Rate control for atrial fibrillation is a common reason for ongoing verapamil prescriptions and may be covered under provincial chronic disease programs when eligibility criteria are met.

Off‑Label Patterns In Canadian Healthcare

Off‑label uses sometimes seen in practice include migraine prophylaxis, symptomatic oesophageal spasm and selected paediatric arrhythmia protocols, though these require specialist oversight.

Off‑label means the prescriber uses a medication for an indication not specifically listed on the official monograph; documentation and informed consent are standard practice.

How It Works In The Body

How does verapamil help my heart and blood pressure in plain language?

Layman’s Explanation (Canadian Patient‑Friendly Tone)

Verapamil is a calcium channel blocker that reduces calcium entry into heart and blood vessel muscle cells.

That slows the heart rate and relaxes blood vessels, which reduces chest pain from angina and helps control fast heart rhythms like atrial fibrillation.

Immediate‑release tablets act faster and need multiple daily doses, while extended‑release tablets provide steadier blood levels with once‑ or twice‑daily dosing.

Clinical Detail From Health Canada Resources

Verapamil is a phenylalkylamine with negative chronotropic (slows heart rate) and negative inotropic (reduces contractility) effects and is classified ATC C08DA01.

Oral ER formulations sustain plasma levels and IV preparations provide rapid effect for acute supraventricular tachycardia in monitored settings.

The drug is metabolized in part by CYP3A4, so interactions with digoxin, beta‑blockers and certain statins can be clinically important.

Dosage & Administration

What doses are typical and how should patients take verapamil?

Standard Regimens Per Canadian Guidelines

For adults with hypertension or angina, a common IR regimen is 80–120 mg three times daily.

ER/SR dosing commonly ranges 180–240 mg once or twice daily depending on the product and patient response.

For acute arrhythmias in monitored settings, IV boluses of 5–10 mg may be used with repeats as clinically required.

Adjustments By Patient Type (With Canadian Clinical Notes)

Start lower in elderly patients and those with hepatic or renal impairment and titrate slowly with monitoring of blood pressure and heart rate.

Pediatric dosing is specialist‑led and varies by protocol; do not attempt home dosing without specific paediatric cardiology instruction.

Avoid combining verapamil with beta‑blockers unless under close specialist supervision because of additive bradycardia and negative inotropy.

Quick titration checklist for pharmacists:

• Confirm indication and baseline vitals (BP, HR).
• Start at lower dose for elderly and impaired hepatic/renal function.
• Arrange ECG monitoring when initiating for arrhythmia control.
• Provide missed‑dose and overdose advice (seek emergency care for severe hypotension or bradycardia).

Contraindications & Side Effects

Who should not take verapamil, and what side effects should patients expect?

Common (Health Canada‑Approved List)

Absolute contraindications include severe hypotension (SBP < 90 mmHg), sick sinus syndrome or 2nd/3rd degree AV block without a pacemaker, severe left ventricular dysfunction or heart failure, cardiogenic shock, and hypersensitivity to verapamil or excipients.

Common adverse effects include constipation, dizziness, headache, nausea and fatigue.

Rare But Serious (With Canadian Pharmacovigilance Data)

Serious but rarer events reported in post‑marketing surveillance include symptomatic hypotension, high‑grade AV block, exacerbation of heart failure and syncope.

Combination with other negative inotropic agents (eg. beta‑blockers), digoxin, and CYP3A4 substrates increases the risk of clinically significant bradyarrhythmias or toxicity.

Monitoring Thresholds

Contact prescriber if resting heart rate < 50 bpm, symptomatic hypotension, new or worsening shortness of breath, or syncope.

Comparable Medicines In Canada

Which drugs are commonly used instead of verapamil, and how do they compare?

Alternatives Table (With DIN References)

Pros And Cons List

Verapamil and diltiazem are non‑dihydropyridines and are preferred for AV nodal suppression and rate control in atrial fibrillation.

Dihydropyridines such as amlodipine and nifedipine are vasoselective and often better tolerated for hypertension without the same degree of negative inotropy.

Choose alternatives based on indication: rate control and arrhythmias favour verapamil/diltiazem; blood pressure control without rate suppression often favours amlodipine.

Current Research & Trends

What recent studies and trends affect how verapamil is used in Canada?

Major Canadian Or International Studies 2022–2025

Recent trials and registry analyses through 2022–2024 focused on rate control strategies in atrial fibrillation, comparative tolerability of non‑dihydropyridine agents, and differences between ER and IR formulations for adherence and outcomes.

Canadian pharmacoepidemiology studies have looked at hospitalisation risks associated with drug interactions such as verapamil with beta‑blockers or digoxin and how provincial formularies shape prescribing patterns.

Emerging research areas include pharmacogenomic predictors of response, real‑world adherence benefits of once‑daily ER products, and cost‑effectiveness comparisons across calcium channel blockers.

For clinicians and informed patients, product pages should link to Health Canada safety communications and high‑quality trials and registries when available.

Common Patient Questions In Canada

What do patients usually ask about calan and verapamil in Canada?

Prescription & Coverage

Can I buy verapamil without a prescription in Canada? No — verapamil products are Rx-only under Health Canada in most cases and pharmacies will require a valid prescription or pharmacist renewal as allowed by provincial rules.

Will my provincial plan cover it? Coverage depends on the program and patient eligibility; check Ontario Drug Benefit, BC PharmaCare and RAMQ formularies and match the product DIN for precise coverage details.

Safety & Interactions

Can I switch between generic brands? Yes, but coordinate with the prescriber or pharmacist — some patients notice small differences in tolerability when manufacturers change.

What about missed doses? For ER products, take when remembered unless close to the next dose; do not double up.

Major interactions to flag: beta‑blockers, digoxin and some statins due to CYP3A4 — arrange ECG monitoring when starting or changing doses for arrhythmia management.

Regulatory Status

How does Health Canada regulate verapamil products and why is the DIN important?

Health Canada Approval Process

Verapamil products undergo Market Authorisation review by Health Canada for quality, safety and efficacy before approval.

Once approved, a Drug Identification Number (DIN) is assigned to a specific product and pack.

DIN Number Relevance

The DIN links the product to Health Canada records and monographs and is critical for provincial reimbursement and safety advisories.

Show DINs on product pages and provide a Health Canada Drug Product Database link for customers to verify details — packs without a Canadian DIN may not be eligible for reimbursement and can face customs issues if imported.

Market Authorisation

Health Canada approval to market a medicine in Canada.

DIN

Unique identifier for a specific drug product and pack.

Rx‑Only

Prescription required for dispensing.

Visual Recommendations

What visuals help patients quickly understand verapamil products on a Canadian product page?

Suggested visuals include a pack and strength carousel with DIN badges, a dosing flowchart contrasting IR versus ER schedules, and a provincial coverage map highlighting Ontario, BC and Quebec with links to formularies.

An interaction matrix icon set for beta‑blockers, digoxin and statins and a safety checklist card for contraindications and monitoring thresholds improve usability.

Use accessible SVGs, alt text and DIN‑linked badges for responsive design and better patient comprehension.

Buying & Storage Advice

How should Canadians buy and store verapamil safely?

In‑Store Vs. Online Canadian Purchase Tips

Present a valid prescription at community pharmacies like Shoppers Drug Mart, Rexall, London Drugs or independent pharmacies.

For online orders, ensure the pharmacy requires prescription upload, displays a valid business licence, and lists DINs for packs.

Compare in‑store and online prices and check manufacturer patient assistance programs if cost is a concern.

Cross‑border purchases are common for some Canadians seeking lower prices, but customs, lack of Canadian DIN and ineligibility for provincial coverage present real risks.

Proper Storage With Canadian Climate Considerations

Store tablets and ER forms at room temperature, ideally 15–30°C, protected from light and humidity.

Avoid storing medicines near heaters in winter or in vehicles where freezing or overheating can occur.

IV forms used in hospitals should be used per product monograph immediately after opening.

Checklist for buyers: verify licence, confirm DIN, upload prescription, and choose a tracked delivery option if ordering online.

Guidelines For Proper Use

What should pharmacists and prescribers tell patients when dispensing verapamil?

Confirm the indication and review the medication list for interactions with beta‑blockers, digoxin and CYP3A4 substrates.

Measure baseline blood pressure and heart rate, and arrange ECG monitoring when initiating therapy for arrhythmia control.

Advise on dosing schedules for IR versus ER, missed‑dose rules, and common side effects such as constipation and dizziness.

When switching brands or generics, coordinate the change during clinic hours where possible and monitor for clinical differences.

Provide a printed counselling checklist and document the counselling in provincial medication records when required.

Delivery Across Canada (English)

Final Notes And Practical Counselling

When you pick up verapamil, check that the product label shows the correct strength, ER/IR designation and the DIN for easy reference.

Keep a written record of blood pressure and pulse readings for the first weeks after starting or changing doses and share those values with your prescriber or pharmacist.

If you experience severe dizziness, fainting, progressive shortness of breath or an unusually slow pulse, seek urgent medical attention.

Do not stop verapamil abruptly; any discontinuation or switching should be supervised by a healthcare professional to avoid rebound hypertension or angina.

If cost is a concern, ask the pharmacist about generic options, manufacturer assistance programs and provincial reimbursement pathways tied to the product DIN.